circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer
Pancreatic cancer is among the most challenging tumors to treat, and due to its immune tolerance characteristics, existing immunotherapy methods are not effective in alleviating the disease. Oncolytic virus therapy, a potential new strategy for treating pancreatic cancer, also faces the limitation o...
Saved in:
| Main Authors: | Taofang Hao, Yuanyuan Li, Qianyao Ren, Ying Zeng, Leyi Gao, Wenbo Zhu, Jiankai Liang, Yuan Lin, Jun Hu, Guangmei Yan, Shuxin Sun, Jing Cai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Molecular Therapy: Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950329924001619 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
by: Chelsae R. Watters, et al.
Published: (2025-03-01) -
Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01) -
Antitumor power of oncolytic HSV engineered with IL-12 and IL-15
by: Lei Zhang, et al.
Published: (2025-09-01) -
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors
by: Selene Ingusci, et al.
Published: (2024-03-01) -
Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation
by: Duo Wan, et al.
Published: (2025-06-01)